Cargando…
PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE.
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429373/ http://dx.doi.org/10.1097/01.HS9.0000851232.61292.37 |
| _version_ | 1784779421162405888 |
|---|---|
| author | Giatra, C. Souravla, E. Darmani, I. Roumelioti, A. Kaouranis, K. Kosmas, P. Bampali, V. Gardeli, D. Papageorgiou, M. Mellios, Z. Karaolidou, F. Tsonis, I. Karatza, M. George, K. Marinos, L. Karakasis, D. Karmiris, T. Bakiri, M. Bouzani, M. |
| author_facet | Giatra, C. Souravla, E. Darmani, I. Roumelioti, A. Kaouranis, K. Kosmas, P. Bampali, V. Gardeli, D. Papageorgiou, M. Mellios, Z. Karaolidou, F. Tsonis, I. Karatza, M. George, K. Marinos, L. Karakasis, D. Karmiris, T. Bakiri, M. Bouzani, M. |
| author_sort | Giatra, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429373 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94293732022-08-31 PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. Giatra, C. Souravla, E. Darmani, I. Roumelioti, A. Kaouranis, K. Kosmas, P. Bampali, V. Gardeli, D. Papageorgiou, M. Mellios, Z. Karaolidou, F. Tsonis, I. Karatza, M. George, K. Marinos, L. Karakasis, D. Karmiris, T. Bakiri, M. Bouzani, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429373/ http://dx.doi.org/10.1097/01.HS9.0000851232.61292.37 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Giatra, C. Souravla, E. Darmani, I. Roumelioti, A. Kaouranis, K. Kosmas, P. Bampali, V. Gardeli, D. Papageorgiou, M. Mellios, Z. Karaolidou, F. Tsonis, I. Karatza, M. George, K. Marinos, L. Karakasis, D. Karmiris, T. Bakiri, M. Bouzani, M. PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. |
| title | PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. |
| title_full | PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. |
| title_fullStr | PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. |
| title_full_unstemmed | PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. |
| title_short | PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. |
| title_sort | pb2100: management of relapsed / refractory (r/r) b-cell non hodgkin lymphoma (b-nhl) with anti-cd20xcd3 bispecific antibody glofitamab. a single center experience. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429373/ http://dx.doi.org/10.1097/01.HS9.0000851232.61292.37 |
| work_keys_str_mv | AT giatrac pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT souravlae pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT darmanii pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT roumeliotia pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT kaouranisk pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT kosmasp pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT bampaliv pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT gardelid pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT papageorgioum pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT melliosz pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT karaolidouf pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT tsonisi pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT karatzam pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT georgek pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT marinosl pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT karakasisd pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT karmirist pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT bakirim pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience AT bouzanim pb2100managementofrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlwithanticd20xcd3bispecificantibodyglofitamabasinglecenterexperience |